Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leflunomide: A safe and effective alternative in systemic lupus erythematosus.
Carrión-Barberà I, Polino L, Mejía-Torres M, Pérez-García C, Ciria M, Pros A, Rodríguez-García E, Monfort J, Salman-Monte TC. Carrión-Barberà I, et al. Autoimmun Rev. 2022 Feb;21(2):102960. doi: 10.1016/j.autrev.2021.102960. Epub 2021 Sep 22. Autoimmun Rev. 2022. PMID: 34560304 No abstract available.
Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Carballo N, Garcia-Alzórriz E, Ferrández O, Navarrete-Rouco ME, Durán-Jordà X, Pérez-García C, Monfort J, Cots F, Grau S. Carballo N, et al. Front Pharmacol. 2021 Nov 29;12:752879. doi: 10.3389/fphar.2021.752879. eCollection 2021. Front Pharmacol. 2021. PMID: 34912219 Free PMC article.
Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Carballo N, Garcia-Alzórriz E, Ferrández O, Navarrete-Rouco ME, Durán-Jordà X, Pérez-García C, Monfort J, Cots F, Grau S. Carballo N, et al. Front Pharmacol. 2022 Mar 7;13:867017. doi: 10.3389/fphar.2022.867017. eCollection 2022. Front Pharmacol. 2022. PMID: 35341215 Free PMC article.
Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study.
Corominas H, Alegre C, Narváez J, Fernández-Cid CM, Torrente-Segarra V, Gómez MR, Pan FM, Morlà RM, Martínez FJR, Gómez-Centeno A, Ares LL, Molina RG, González-Albo SP, Dalmau-Carolà J, Pérez-García C, Álvarez CB, Ercole L, Terrancle MÁ; ACT-AXIS Study Group. Corominas H, et al. Medicine (Baltimore). 2019 Jun;98(26):e15947. doi: 10.1097/MD.0000000000015947. Medicine (Baltimore). 2019. PMID: 31261500 Free PMC article.
Standards of care for patients with spondyloarthritis.
Abad MÁ, Ariza RA, Aznar JJ, Batlle E, Beltrán E, de Dios Cañete J, de Miguel E, Escudero A, Fernández-Carballido C, Gratacós J, Loza E, Linares LF, Montilla C, Ramos MM, Mulero J, Queiro R, Raya E, Lozano CR, Moreno JR, Sanz J, Silva-Fernández L, Torre Alonso JC, Zarco P, Fernández-Sueiro JL, Juanola X; 2e study group; Spanish Society of Rheumatology. Abad MÁ, et al. Rheumatol Int. 2014 Feb;34(2):165-70. doi: 10.1007/s00296-013-2934-6. Epub 2014 Jan 4. Rheumatol Int. 2014. PMID: 24390635 Review.
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Moreno-Ramos MJ, Sanchez-Piedra C, Martínez-González O, Rodríguez-Lozano C, Pérez-Garcia C, Freire M, Campos C, Cáliz-Caliz R, Calvo J, Blanco-Madrigal JM, Pérez-Gómez A, Moreno-Martínez MJ, Linares L, Sánchez-Alonso F, Sastré C, Castrejón I. Moreno-Ramos MJ, et al. Rheumatol Ther. 2022 Aug;9(4):1031-1047. doi: 10.1007/s40744-022-00446-9. Epub 2022 Apr 25. Rheumatol Ther. 2022. PMID: 35467242 Free PMC article.
232 results